Global Treatment Planning Systems And Advanced Image Processing Market by Application (Adaptive Radiotherapy, Dose Accumulation) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global treatment planning systems and advanced imaging processing market was valued at USD1.6 billion in 2020. It is projected to grow at a compound annual rate (CAGR of 7.8%) between 2021 and 2028. Global cancer incidence is increasing rapidly, which drives the need for accurate and innovative oncology treatment methods. The market is growing due to the evolving healthcare IT sector and supporting infrastructure, the increasing adoption of Artificial Intelligence and Machine Learning (ML), rising investments in oncology treatments and care segments, as well as the increased demand for new treatment solutions. Purdue Pharma L.P. is investing in its oncology R&D in order to diversify its scientific research in high-unmet medical need areas, and thus establishing a portfolio that could deliver new cancer treatments to patients in the coming years.

Alarming statistics are emerging about the rapidly rising incidence of cancer and death from cancer at regional and global levels. This will increase the demand for new treatment methods in oncology. According to Globocan estimates, in 2020 there were approximately 19.3 million new cases of cancer and 10.0 million deaths from cancer. These numbers included breast cancer (11.7%), lung cancer (10.4%), colorectal and prostate cancer (10.0%), and stomach cancer (5.6%).

It is also estimated that more than 28.4 millions new cases of cancer will be diagnosed each year by 2040, an increase of 47.0% over 2020. An accurate diagnosis is essential to ensure that the appropriate treatment plans are implemented. Radiotherapy is becoming a popular and affordable treatment option. Radiation therapy is a popular choice for cancer patients, with around 50% choosing it due to its efficiency.

Radiotherapy is continually innovating new technologies that can transform treatment. The healthcare infrastructure is changing and market players are looking for growth opportunities in emerging markets to develop treatment planning. In addition, government initiatives and support for public-private partnerships in oncology radiotherapy will help accelerate product development. Elekta, for example, was approved by the Mexican government to provide radiation therapy solutions in 2018. To support advanced radiation therapy, the Victorian RapidPlan Project was launched by the Australian government. Barwon Health Foundation also inaugurated the Andrew Love Cancer Centre Chemotherapy Days Ward and Oncology Pharmacy. Varian Medical Systems collaborated to offer treatment planning and radiation therapy systems.

Market leaders are increasingly using artificial intelligence and machine-learning in their oncology software solutions. This helps to improve diagnosis, treatment plan and management of cancer. AI/ML-enabled algorithms can be used to segment images and detect clinically important areas. AI is used in cancer screening and diagnosis. It also aids in treatment planning and reduces the risk of collateral tissue injury. Organizations are taking up numerous initiatives to integrate AI/ML in their solutions. The Data Science Institute was established by the American College of Radiology to encourage collaboration between radiologists and private and public agencies in order to develop and adopt AI-based imaging solutions. The American Society of Clinical Oncology, American Society for Radiation Oncology and American Society for Clinical Oncology also launched CancerLinQ. In addition, the National Institute of Health created Big Data to Knowledge.

AI-enabled cancer prognosis would allow for early detection of cancer via machine learning and deep learning algorithms. In 2019, RaySearch Laboratories presented a U.S. FDA-approved treatment plan system that uses machine learning capabilities. With the increasing accessibility of radiotherapy centres and strategic collaborations between major players, treatment planning systems are seeing widespread adoption. Accuray Inc partnered with several Japanese hospitals to provide them with Accuray Radixact Systems in 2020. This collaboration will increase Accuray's visibility in Japan's oncology market.

Players in the market for treatment planning systems are constantly innovating to provide the best possible solutions for the increasing demand for oncology treatment options. Accuray Inc, for example, launched Synchrony Motion Tracking and Correct technology in April 2019 for its Radixact system. Elekta was also certified by the EU Medical Device Regulation (MDR), for its new Elekta Harmony linear accelerator, in September 2020. The companies also plan to collaborate with market players to expand their geographical footprints and geographic presence. Accuray Inc partnered with Brainlab in order to improve Accuray's CyberKnife platform treatments for neuro-radiosurgery markets. This collaboration took place in October 2020. In April 2020, ViewRay Inc partnered with VieCure in order to integrate AI informatics into personalized care options for cancer. Brainlab purchased VisionTree in January 2020. This acquisition was designed to improve patient-driven outcomes in regard to treatment planning, image generation, and registries.

Component Insights

In 2020, the treatment planning software segment was the dominant market for advanced image processing and treatment planning systems. It held the largest revenue share at 87.5%. This is due to an increasing prevalence of cancer worldwide and a rising demand for accurate oncology treatment solutions. Because of its effectiveness in radiotherapy treatment, treatment planning software is becoming more popular. The software provides radiologists with data on dose distribution, tissue energy level penetration, and beamline navigation in order to minimize collateral damage. Its large market share can also be attributed to the development of healthcare infrastructure and public-private partnerships.

Fujitsu, for example, collaborated with University of Toronto in February 2021 to create and streamline radiotherapy planning software. Auto-contouring software also accounted for 28.6% of the market share in treatment planning software solutions. Manual contouring is not accurate, efficient, or standardized, which limits its adoption. This has led to an increase in demand for fully automatic contouring software for radiotherapy. Market development is also being influenced by product launches in the auto contouring segment. Mirada Medical, for instance, launched DLC Expert online auto-conturing software in June 2020. It has over 50 registered users.

The forecast period will see a significant increase in revenue share for the advanced image processing segment. The fastest-growing segment in healthcare is medical imaging software. It includes multiple image modalities. These software solutions can be found as either open-source or customized paid sources. While the demand for radiology services worldwide is growing, the number of radiologists who are trained is decreasing at half the pace. The shortage of qualified personnel is driving demand for advanced image processing technologies.

Technique Insights

In-room imaging dominated the market in treatment planning systems and advanced images processing in 2020 and represented 55.5% of the total revenue. This is due to technological advances in radiotherapy solutions. In-room imaging is a process that captures images during treatment and provides real-time data. These procedures are necessary for dose volume reduction, normal tissue radiotherapy toxic reduction, and to provide precise and accurate treatment. Radiologists can overcome the challenges presented by target lesions and movable tumors with in-room imaging. In-room imaging is gaining market share due to increasing awareness.

In-room imaging offers many benefits, including improved target location, decreased dosage toxicity, shorter treatment courses, and better tumor control. In-room imaging market players are continually launching new products. In February 2019, Canon Medical Systems introduced Acquilion Prime, Acquilion Lighting 80 and AcquilionLB, which combine radiotherapy packages to enhance the in-room image process.

The forecast period will see a 8.2% CAGR in 3D image reconstruction. These 3D image projections are made from image data using various reconstruction techniques, such as visualization, triangulation, photometric stereo handling and multiple Kinect capture systems. 3D image reconstruction is useful in planning treatment processes. It allows for optimal treatment process realization, application selection, dosage distribution planning, as well as minimizing collateral tissue injury. Growing demand for precise oncology treatment methods and tackling increasing levels of cancer worldwide is driving 3D image reconstruction to grow.

Application Insights

The market for advanced image processing and treatment planning systems was dominated by the segment of image registration in 2020. It accounted for 27.6% of the largest revenue share. This is due to the important role image registration and creation image datasets play during a treatment planning process. Image registration creates real-time image data from multiple imaging modalities, anatomical atlases, and other sources to help guide target volume and tissue definition. These solutions perform validations of dose distribution, contours and dosage accumulation using the developed imaged data sets over the course of the therapy. These solutions can be used to guide dose accumulation and mapping. RaySearch Laboratories is one of the key players in developing image registration validation solutions. Varian Medical Systems is another.

Adaptive radiotherapy will see the greatest growth in the forecast period. Adaptive radiotherapy provides altered radiation therapy to correct for functional and anatomical changes that occur during radiotherapy. In-room imaging, image registration algorithms and image segmentation are all part of adaptive radiotherapy. It is widely used to treat head, neck and stomach cancers. Adaptive radiotherapy is seeing positive growth due to the increasing number of cancer treatment centers. Varian, for example, introduced Ethos Solution in September 2019 to enable adaptive radiotherapy powered with artificial intelligence.

Regional Insights

North America was the dominant market in 2020 and accounted for 38.8% of the total revenue. This is due to the rapid development in healthcare infrastructure and increased healthcare spending. Treatment planning systems are also being driven by rising global cancer rates. This market has seen a rise in demand for advanced, accurate and effective cancer treatment in North America.

Market development and growth are supported by the presence of advanced healthcare facilities, cancer research institutes, and an increase in disposable income that is matched with an existing reimbursement system. Cancer is the second leading cause for death in North America. According to Globocan estimates for 2020, the U.S. had a total of 2.25 million new cases and 0.6million deaths from cancer. The region's cancer mortality has declined since 1991, thanks to advances in treatment and early detection.

The Asia Pacific market will see a 8.8% CAGR over the forecast period, due to the expansion of many emerging economies like India and China. Market growth is attributed to the rapid healthcare advances and widespread adoption of IT-based healthcare solutions in emerging markets. Market growth is supported by rising cancer rates and increased healthcare spending, both public and private. According to Globocan 2020, Asia Pacific saw 9,503,710 cases of cancer. Initiatives are being taken by organizations to increase awareness and speed up penetration. Asia Pacific Signal and Information Processing Association hosts workshops and seminars on topics such as image processing and healthcare information technologies.

Market Share Insights & Key Companies

To gain market share, key companies are using business strategies that include product launches, partnerships, agreements, and continuous new launches. These market leaders have recently introduced new software systems to expand their solution portfolio. Elekta launched the new linear accelerator Elekta Harmony in September 2020 to increase their market penetration strategies. The following are some of the most prominent players in advanced image processing and treatment planning market:

• Accuray Incorporated

• Elekta

• Koninklijke PHILIPS N.V.

• RaySearch Laboratories

• Varian Medical Systems

• Brainlab

• Prowess Inc.

• DOSIsoft SA

• ViewRay Inc.

• MIM Software Inc.

Up Market Research published a new report titled “Treatment Planning Systems And Advanced Image Processing Market research report which is segmented by Application (Adaptive Radiotherapy, Dose Accumulation), By Players/Companies Elekta, Brainlab, ViewRay Inc, RaySearch Laboratories, Varian Medical Systems, Prowess Inc, DOSIsoft SA, Koninklijke PHILIPS NV, MIM Software Inc, Accuray Incorporated”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Treatment Planning Systems And Advanced Image Processing Market Report Segments:

The market is segmented by Application (Adaptive Radiotherapy, Dose Accumulation).

Treatment Planning Systems And Advanced Image Processing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Treatment Planning Systems And Advanced Image Processing Market

Overview of the regional outlook of the Treatment Planning Systems And Advanced Image Processing Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Treatment Planning Systems And Advanced Image Processing Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Treatment Planning Systems And Advanced Image Processing Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Adaptive Radiotherapy

                2. Dose Accumulation

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Treatment Planning Systems And Advanced Image Processing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Treatment Planning Systems And Advanced Image Processing Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.